Medicines
Every medicine in the registers under its name, current ones first.
4 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| MOTPOLY XR100mg | 150mg | 200mg · Capsule, extended release | Lacosamide | United States | Marketed | 2023 |
| PYQUVI22.75mg/ml · Suspension | Deflazacort | United States | Marketed | 2025 |
| VIGADRONE500mg/packet · For solution | Vigabatrin | United States | Marketed | 2018 |
| ZELVYSIA100mg/packet | 500mg/packet · Powder | Sapropterin | United States | Marketed | 2025 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 4 | 4 | 0 | CompaniesAll medicines |
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 4
- Countries
- 1
- Roles
- Authorisation holder
Work with Prognia
Keep Aucta’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a call